133 related articles for article (PubMed ID: 33905741)
1. Exploration of 7-azaindole-coumaranone hybrids and their analogues as protein kinase inhibitors.
Qhobosheane MA; Beteck RM; Baratte B; Robert T; Ruchaud S; Bach S; Legoabe LJ
Chem Biol Interact; 2021 Jul; 343():109478. PubMed ID: 33905741
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of 7-azaindole derivatives bearing benzocycloalkanone motifs as protein kinase inhibitors.
Qhobosheane MA; Legoabe LJ; Josselin B; Bach S; Ruchaud S; Petzer JP; Beteck RM
Bioorg Med Chem; 2020 Jun; 28(11):115468. PubMed ID: 32284225
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and evaluation of 7-azaindazolyl-indolyl-maleimides as glycogen synthase kinase-3β (GSK-3β) inhibitors.
Ye Q; Shen Y; Zhou Y; Lv D; Gao J; Li J; Hu Y
Eur J Med Chem; 2013 Oct; 68():361-71. PubMed ID: 23994329
[TBL] [Abstract][Full Text] [Related]
4. Janus kinase 2 inhibitors. Synthesis and characterization of a novel polycyclic azaindole.
Wang T; Duffy JP; Wang J; Halas S; Salituro FG; Pierce AC; Zuccola HJ; Black JR; Hogan JK; Jepson S; Shlyakter D; Mahajan S; Gu Y; Hoock T; Wood M; Furey BF; Frantz JD; Dauffenbach LM; Germann UA; Fan B; Namchuk M; Bennani YL; Ledeboer MW
J Med Chem; 2009 Dec; 52(24):7938-41. PubMed ID: 20014869
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of C3 substituted chalcone-based derivatives of 7-azaindole as protein kinase inhibitors.
Qhobosheane MA; Legoabe LJ; Josselin B; Bach S; Ruchaud S; Beteck RM
Chem Biol Drug Des; 2020 Dec; 96(6):1395-1407. PubMed ID: 32558155
[TBL] [Abstract][Full Text] [Related]
6. N-substituted azaindoles as potent inhibitors of Cdc7 kinase.
Bryan MC; Falsey JR; Frohn M; Reichelt A; Yao G; Bartberger MD; Bailis JM; Zalameda L; Miguel TS; Doherty EM; Allen JG
Bioorg Med Chem Lett; 2013 Apr; 23(7):2056-60. PubMed ID: 23481650
[TBL] [Abstract][Full Text] [Related]
7. 1,2-Disubstituted indole, azaindole and benzimidazole derivatives possessing amine moiety: a novel series of thrombin inhibitors.
Takeuchi K; Bastian JA; Gifford-Moore DS; Harper RW; Miller SC; Mullaney JT; Sall DJ; Smith GF; Zhang M; Fisher MJ
Bioorg Med Chem Lett; 2000 Oct; 10(20):2347-51. PubMed ID: 11055353
[TBL] [Abstract][Full Text] [Related]
8. Discovery of potent and bioavailable GSK-3beta inhibitors.
Gong L; Hirschfeld D; Tan YC; Heather Hogg J; Peltz G; Avnur Z; Dunten P
Bioorg Med Chem Lett; 2010 Mar; 20(5):1693-6. PubMed ID: 20138512
[TBL] [Abstract][Full Text] [Related]
9. ROCK inhibitors 4: Structure-activity relationship studies of 7-azaindole-based rho kinase (ROCK) inhibitors.
Bandarage UK; Court J; Gao H; Nanthakumar S; Come JH; Giroux S; Green J
Bioorg Med Chem Lett; 2021 Feb; 33():127721. PubMed ID: 33259926
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and evaluation of 3,5-disubstituted 7-azaindoles as Trk inhibitors with anticancer and antiangiogenic activities.
Hong S; Kim J; Seo JH; Jung KH; Hong SS; Hong S
J Med Chem; 2012 Jun; 55(11):5337-49. PubMed ID: 22575050
[TBL] [Abstract][Full Text] [Related]
11. The azaindole framework in the design of kinase inhibitors.
Mérour JY; Buron F; Plé K; Bonnet P; Routier S
Molecules; 2014 Nov; 19(12):19935-79. PubMed ID: 25460315
[TBL] [Abstract][Full Text] [Related]
12. Approaches to a multitargeting drug development: first profiled 3- ethoxycarbonyl-1-aza-9-oxafluorenes representing a perspective compound class targeting Alzheimer disease relevant kinases CDK1, CDK5 and GSK-3β.
Hilgeroth A; Tell V; Kramer S; Totzke F; Schachtele C
Med Chem; 2014; 10(1):90-7. PubMed ID: 23477782
[TBL] [Abstract][Full Text] [Related]
13. Towards discovery of new leishmanicidal scaffolds able to inhibit
Martínez de Iturrate P; Sebastián-Pérez V; Nácher-Vázquez M; Tremper CS; Smirlis D; Martín J; Martínez A; Campillo NE; Rivas L; Gil C
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):199-210. PubMed ID: 31752556
[TBL] [Abstract][Full Text] [Related]
14. Structure-based design and optimization of potent renin inhibitors on 5- or 7-azaindole-scaffolds.
Matter H; Scheiper B; Steinhagen H; Böcskei Z; Fleury V; McCort G
Bioorg Med Chem Lett; 2011 Sep; 21(18):5487-92. PubMed ID: 21840215
[TBL] [Abstract][Full Text] [Related]
15. Novel 5-azaindole factor VIIa inhibitors.
Riggs JR; Hu H; Kolesnikov A; Leahy EM; Wesson KE; Shrader WD; Vijaykumar D; Wahl TA; Tong Z; Sprengeler PA; Green MJ; Yu C; Katz BA; Sanford E; Nguyen M; Cabuslay R; Young WB
Bioorg Med Chem Lett; 2006 Jun; 16(12):3197-200. PubMed ID: 16621549
[TBL] [Abstract][Full Text] [Related]
16. ROCK inhibitors 3: Design, synthesis and structure-activity relationships of 7-azaindole-based Rho kinase (ROCK) inhibitors.
Bandarage UK; Cao J; Come JH; Court JJ; Gao H; Jacobs MD; Marhefka C; Nanthakumar S; Green J
Bioorg Med Chem Lett; 2018 Aug; 28(15):2622-2626. PubMed ID: 30082069
[TBL] [Abstract][Full Text] [Related]
17. Design of potent IGF1-R inhibitors related to bis-azaindoles.
Nemecek C; Metz WA; Wentzler S; Ding FX; Venot C; Souaille C; Dagallier A; Maignan S; Guilloteau JP; Bernard F; Henry A; Grapinet S; Lesuisse D
Chem Biol Drug Des; 2010 Aug; 76(2):100-6. PubMed ID: 20545947
[TBL] [Abstract][Full Text] [Related]
18. The importance of indole and azaindole scaffold in the development of antitumor agents.
Han Y; Dong W; Guo Q; Li X; Huang L
Eur J Med Chem; 2020 Oct; 203():112506. PubMed ID: 32688198
[TBL] [Abstract][Full Text] [Related]
19. Isosteric replacements of the carboxylic acid of drug candidate VX-787: Effect of charge on antiviral potency and kinase activity of azaindole-based influenza PB2 inhibitors.
Boyd MJ; Bandarage UK; Bennett H; Byrn RR; Davies I; Gu W; Jacobs M; Ledeboer MW; Ledford B; Leeman JR; Perola E; Wang T; Bennani Y; Clark MP; Charifson PS
Bioorg Med Chem Lett; 2015 May; 25(9):1990-4. PubMed ID: 25827523
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of Coumarin Derivatives as Versatile Scaffolds for GSK-3β Enzyme Inhibition.
Francisco CS; Javarini CL; de S Barcelos I; Morais PAB; de Paula H; de S Borges W; Neto ÁC; Lacerda V
Curr Top Med Chem; 2020; 20(2):153-160. PubMed ID: 31648640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
